What I want patients and clinicians to take away from this is that if you or your patient has obesity, established cardiovascular disease, type 2 diabetes, CKD, HFpEF, MASH, or sleep apnea, this drug class should be a serious part of the treatment conversation
Mistake 5: Assuming permanent damage
Glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for diabetes management, have emerged as a promising treatment for obesity
Inhaled tea polyphenol-loaded nanoparticles coated with platelet membranes largely attenuate asthmatic inflammation
There are two blood tests that are used to help diagnose your condition
After you eat, food travels through the oesophagus to the stomach, where it is broken down by gastric acid and enzymes